BMS-813160
BMS-813160 is the first dual CCR2/CCR5 antagonist to enter Clinical development for cardiovascular.
Product Specifications
Stability
≥ 2 years
Purity
>98% (HPLC)
Weight
484.64
Molecular Formula
C25H40N8O2
Notes
Research use only, not for human use.
Receptor
CCR2|CCR5
CAS Number
1286279-29-5
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1039700-01 0.02 mg (E-Coli)
Recombinant Triticum aestivum Nuclear ribonuclease Z (ELAC)
Ask
View Details MBS1039700-02 0.1 mg (E-Coli)
Recombinant Triticum aestivum Nuclear ribonuclease Z (ELAC)
Ask
View Details 
MBS1039700-03 0.02 mg (Yeast)
Recombinant Triticum aestivum Nuclear ribonuclease Z (ELAC)
Ask
View Details 
MBS1039700-04 0.1 mg (Yeast)
Recombinant Triticum aestivum Nuclear ribonuclease Z (ELAC)
Ask
View Details MBS1039700-05 0.02 mg (Baculovirus)
Recombinant Triticum aestivum Nuclear ribonuclease Z (ELAC)
Ask
View Details 
MBS1039700-06 0.02 mg (Mammalian-Cell)
Recombinant Triticum aestivum Nuclear ribonuclease Z (ELAC)
Ask
View Details